Dr. Martens maintains full-year outlook as US growth continues
The British footwear brand said in a trading update that its performance since the start of the 2027 financial year had been in line with expectations and that it was maintaining its full-year guidance
Ahead of its annual general meeting, Dr. Martens provided a trading update in which it was highlighted that its largest market, the US, continues to grow, with a particularly “encouraging” performance in the wholesale sector.
Japan and South Korea also performed well, while European markets traded in line with expectations despite a challenging consumer environment.
As a result, the company confirmed that it is still on track to achieving the strategic goals set out alongside its annual results in May.
These include increasing the proportion of full-price sales in the UK and Germany, launching a new range of sandals, introducing new retail concepts in major cities and enhancing the operating model and technology.
Image Credits: haveagood-holiday.com
Related news
Related Events
Related Organizations
-
-
Footwear Consumer 2030
A study reflecting on the main global consumer trends and the key changes for the footwear industry.
-
World Footwear Public Calendar
Click here to subscribe an updated version of the calendar displaying the footwear trade shows.
-
-
-
Media Partners
Media Partners
-
Shoes Report
MPA Style
SHOES-MAGAZINE.COM
SERMA